TABLE 2 

Summary of capsule-typing results based on country of isolation and associated clinical condition

Country (no. of isolates)No. of isolates from indicated clinical condition with indicated capsule type
InvasiveCarrierUnknown
Total no.abcdTotal no.abcdTotal no.abcd
Spain (45)4325162211
France (36)302091211321
USA (28)18126211853
Canada (12)127a5
Iceland (12)12372
New Zealand (10)6644
Norway (3)2211
Switzerland (3)21111
Australia (1)11
Russia (1)11
Total (150)12676454113731211713
  • a Isolate CAN8 is nonencapsulated due to a truncated csaA gene but was included as a type a isolate for the purposes of this analysis.